Rigel Pharmaceuticals announces inducement grants

Rigel Pharmaceuticals, Inc. has announced the issuance of inducement grants under NASDAQ Listing Rule 5635(c)(4). These grants are typically awarded to new employees as an incentive to join the company. The announcement follows standard procedure for equity compensation. Rigel Pharmaceuticals continues to utilize such grants as part of its strategy to attract and retain talent in the competitive biopharmaceutical industry.